CareCloud (CCLD) Company Report

CareCloud delivered strong financial results for full year 2025, with revenue of $120.5 million and GAAP net income of $10.8 million, marking its first full year of positive EPS at $0.10 since its 2014 IPO.
The company generated $20.5 million in non-GAAP free cash flow in 2025, a significant increase from $13.2 million in 2024, which enabled it to fund multiple acquisitions and fully repay its Provident Bank credit line.
Strategic initiatives in 2025 included the acquisition of Medsphere Systems and MAP App, expanding its market reach into inpatient hospitals, and the launch of its flagship AI platform, stratusAI Desk Agent, in December.
For 2026, CareCloud provided guidance of revenue between $128 million and $130 million, Adjusted EBITDA of $29 million to $31 million, and GAAP EPS of $0.20 to $0.23, representing over 100% growth from 2025.

6 hours ago

Transcript

CareCloud Reports Strong Full-Year 2025 Results, Strategic Acquisitions, and Positive 2026 Guidance

CCLD

Earnings

M&A

Guidance Update

CareCloud reported full-year 2025 revenue of $120.5 million, a nearly 9% year-over-year increase, and achieved its first full year of positive GAAP EPS at $0.10 since its 2014 IPO.
The company generated $20.5 million in non-GAAP free cash flow for 2025, representing over 500% growth from 2023, which enabled it to fund multiple acquisitions and fully repay its Provident Bank credit line by year-end.
CareCloud completed strategic acquisitions in 2025, including Medsphere Systems and MAP App, expanding its market reach into the inpatient hospital sector and enhancing its AI capabilities without common shareholder dilution.
The company launched its flagship AI product, stratusAI Desk Agent, in December 2025 and provided 2026 guidance forecasting revenue of $128 million-$130 million and GAAP EPS of $0.20-$0.23 per share, projecting over 100% growth from 2025.

6 hours ago

Transcript

CareCloud Reports Strong Q4 and Full-Year 2025 Results with Positive EPS and Strategic Growth Initiatives

CCLD

Earnings

Guidance Update

M&A

CareCloud (CCLD) reported strong financial performance for full year 2025, with revenue of $120.5 million and GAAP net income of $10.8 million, marking its first full year of positive EPS at $0.10 since its 2014 IPO.
The company generated non-GAAP free cash flow of $20.5 million in 2025, a significant increase from $13.2 million in 2024, which funded multiple strategic acquisitions, including Medsphere Systems and MAP App, without common shareholder dilution, and allowed for the full repayment of its credit line.
CareCloud launched its stratusAI Desk Agent in December 2025 and established an AI Center of Excellence in April 2025, with plans to further expand its AI product suite and integrate AI across its platforms in 2026.
For 2026, the company provided guidance of revenue between $128 million and $130 million, Adjusted EBITDA of $29 million to $31 million, and GAAP EPS of $0.20 to $0.23 per share, representing over 100% growth from 2025.

7 hours ago

Transcript

CareCloud Announces Q4 and Full Year 2025 Results and 2026 Guidance

CCLD

Earnings

Guidance Update

New Projects/Investments

CareCloud reported FY 2025 revenue of $120.5 million, a net income of $10.8 million, and Adjusted EBITDA of $27.5 million, representing year-over-year increases of 8.7%, 37.5%, and 14.5% respectively.
The company generated $20.3 million in free cash flow for FY 2025, fully funding two strategic acquisitions in August and October 2025, and ended the year with $0 debt.
CareCloud provided FY 2026 guidance, projecting revenue between $128 million and $132 million, Adjusted EBITDA between $29 million and $31 million, and Earnings per Share between $0.20 and $0.23.
The company launched its AI Center of Excellence in April 2025, developing and deploying new AI solutions like stratusAI Desk Agent and cirrusAI Notes, and plans to expand its AI product suite and integrate AI across its Medsphere portfolio in 2026.

11 hours ago

Presentation

CareCloud Announces Preferred Stock Dividend Payments

CCLD

Dividends

Delisting/Listing Issues

CareCloud's Board of Directors declared monthly cash dividends for its 8.75% Series A and Series B Cumulative Redeemable Perpetual Preferred Stock for January, February, and March 2026, with a dividend per share of $0.18229 for each.
An additional dividend payment of $0.18229 per share was declared for the Series B Preferred Stock for January, February, and March 2026, due to an arrearage.
The Series A Preferred Stock was delisted from the Nasdaq Global Market after its mandatory conversion into common stock on March 6, 2025.
The Series B Preferred Stock (CCLDO) has redemption prices that vary by date: $25.50 per share until February 15, 2026; $25.25 per share from February 15, 2026, to February 15, 2027; and $25.00 per share from February 25, 2027.

Jan 20, 2026, 1:10 PM

8-K

CareCloud Brings Wellsoft to Urgent Care Market

CCLD

New Projects/Investments

Product Launch

CareCloud announced that Affinity Urgent Care selected its Wellsoft emergency department information system (EDIS), marking Wellsoft's entry into the urgent care market.
Wellsoft, which joined CareCloud's product portfolio through its acquisition of Medsphere in August 2025, is an award-winning platform recognized by KLAS as a category leader in emergency medicine.
This agreement with Affinity is considered an early indicator of a larger national opportunity for CareCloud in the urgent care sector, which includes an estimated 11,000 facilities.

Jan 8, 2026, 1:00 PM

Press Release

CareCloud Unveils Stratus AI Desk Agent for Healthcare Front Desks

CCLD

Product Launch

New Projects/Investments

CareCloud introduced Stratus AI Desk Agent, an AI voice agent designed to modernize patient phone access in healthcare by answering, understanding, and resolving patient calls through natural, human-like conversations, available 24/7.
The solution supports unlimited simultaneous calls, integrates with CareCloud's platforms and other EHR/practice management systems, and handles high-volume tasks such as scheduling, prescription refills, and general inquiries.
Stratus AI Desk Agent demonstrates a 97% AI call resolution success rate, autonomously handling nearly 80% of inbound calls, leading to reduced staff workload and improved patient access.
The product offers significant financial benefits, with an illustrative example showing $7,200 in monthly savings or over $86,000 annually and an ROI north of 200% for a practice receiving 2,000 inbound calls per month.
It is HIPAA compliant, supports 32+ languages with auto-detection, and typically has a go-live time of two to four weeks.

Dec 17, 2025, 8:00 PM

Transcript

CareCloud Introduces Stratus AI Desk Agent for Healthcare Front Desk Automation

CCLD

Product Launch

New Projects/Investments

CareCloud has launched Stratus AI Desk Agent, an AI voice agent designed to automate patient phone access in healthcare, available 24/7 to answer, understand, and resolve patient calls through natural, human-like conversations.
The solution addresses the unsustainability of traditional front desk models, which face staffing shortages and high call volumes, by handling high-volume, repeatable interactions such as scheduling, prescription refills, and general inquiries.
Stratus AI is HIPAA compliant, integrates natively with CareCloud's platforms and other EHR/practice management systems via APIs, and supports over 32 languages with auto-detection.
In real-world usage, Stratus AI achieves a 97% AI call resolution success rate, autonomously handling nearly 80% of inbound calls. This results in significant cost savings, with an illustrative example showing approximately $7,200 in monthly savings and a projected ROI north of 200% annually for practices.
CareCloud offers a 30-day risk-free trial and a pricing model based on successful calls resolved by the AI, allowing for customization based on organization size and workflow complexity.

Dec 17, 2025, 8:00 PM

Transcript

CareCloud Launches stratusAI Desk Agent

CCLD

Product Launch

New Projects/Investments

CareCloud, Inc. (Nasdaq: CCLD, CCLDO) announced the full launch of stratusAI Desk Agent™, an AI-driven phone receptionist designed to modernize and automate patient phone interactions.
This new solution provides 24/7, no-wait phone access through autonomous, human-like AI conversations, handling tasks such as appointment scheduling, prescription refill requests, and call triage.
Edsel Holden II, MD, owner of The Lung Center, reported that stratusAI Desk Agent is effectively managing nearly 80% of their inbound calls.
CareCloud estimates the total addressable market for stratusAI Front Desk in the U.S. likely exceeds $4 billion annually, representing a significant growth opportunity in healthcare technology.

Dec 15, 2025, 1:00 PM

Press Release

CCLD Reports Strong Q3 2025 Results, Raises Revenue Guidance, and Details Strategic Acquisitions and AI Progress

CCLD

Earnings

Guidance Update

M&A

CareCloud reported Q3 2025 revenue of $31.1 million, a 9% increase year-over-year, and adjusted EBITDA of $7.7 million, up 13%. The company raised its full-year 2025 revenue guidance to $117-$119 million from the previous $111-$114 million, while reaffirming adjusted EBITDA and GAAP EPS guidance.
The company completed two strategic acquisitions: MedSphere Systems Corporation for $16.5 million in August, significantly expanding its presence into the inpatient hospital market, and MapApp in October, enhancing analytics and benchmarking capabilities.
CareCloud is advancing its AI strategy with the Agentic AI Front Desk Solution, currently in advanced pilot testing and scheduled for formal launch in mid-December, which autonomously manages patient calls and achieved a 70% success rate in pilot deployments.
The company generated $19.9 million in cash flow from operations for the nine months ended September 30, 2025, and has rapidly reduced the credit facility balance for the MedSphere acquisition to $4.9 million, with plans for full repayment soon.